Preparation of IPSC for Cell Gene Editing for the Treatment of AATD
Key facts
- Who runs it
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 3 people, planned
- Started
- 15 Jan 2025
- Planned end
- 28 Feb 2026
- Type of study
- Interventional
- Treatments tested
- iPSC generation
- Record updated
- 24 March 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- age ≥ 18 years at the time of signing the ICF
- diagnosis of severe AATD (2 pathological variants)
Who cannot take part
- subject under augmentation therapy
- incapability to give informed consent
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Alpha 1-antitrypsin (AAT) deficiency is a genetic condition that leads to lung and/or liver diseases; current treatment of weekly augmentation of AAT addresses only lung diseases with moderate efficacy. Novel treatments based on gene editing can restore physiological levels of AAT and address lung and liver disease.
Read full original descriptionShow less
The aim is to generate induced pluripotent stem cells (iPSC) from blood and urine of patients with different severe Alpha1-antitrypsin deficiency (AATD) genotypes. Further, the iPSC will be differentiated into hepatocytes (iHep). Since hepatocytes are the main producers of AAT, the iHep will be used to test different approaches of gene editing to correct various mutations. Gene editing will be conducted at University of Bern (Switzerland)
The group in the trial
- severe AATD patientsOther group
blood samples from severe AATD patients to obtain iPSC cells
Treatment: iPSC generation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Preparation of Large-scale Patient-specific Induced Pluripotent Stem Cells (iPSC) Library for Cell Gene Editing for the Treatment of Alpha1-antitrypsin Deficiency
- Record updated
- 24 March 2025